tiprankstipranks
Harvard Bioscience (HBIO)
NASDAQ:HBIO
US Market

Harvard Bioscience (HBIO) Income Statement

Compare
189 Followers

Harvard Bioscience Income Statement

Last quarter (Q3 2024), Harvard Bioscience's total revenue was $21.97M, a decrease of -13.38% from the same quarter last year. In Q3, Harvard Bioscience's net income was $-4.80M. See Harvard Bioscience’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 112.25M$ 113.33M$ 118.90M$ 102.10M$ 116.18M
Gross Profit
$ 66.07M$ 60.82M$ 67.65M$ 58.04M$ 64.32M
Operating Expenses
$ 64.18M$ 67.98M$ 65.59M$ 57.82M$ 62.48M
Depreciation and Amortization
$ 7.00M$ 7.58M$ 7.62M$ 7.63M$ 7.73M
EBITDA
$ 8.03M$ 944.00K$ 11.31M$ 5.49M$ 7.50M
Operating Income
$ 1.89M$ -7.17M$ 1.40M$ -585.00K$ 1.47M
Other Income/Expenses
$ -4.45M$ -2.25M$ -2.21M$ -7.51M$ -5.88M
Pretax Income
$ -2.56M$ -9.18M$ -140.00K$ -7.29M$ -5.50M
Net Income
$ -3.42M$ -9.52M$ -288.00K$ -7.81M$ -4.69M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -0.08$ -0.23$ -0.01$ -0.20$ -0.12
Diluted EPS
$ -0.08$ -0.23$ -0.01$ -0.20$ -0.12
Weighted Average Shares Outstanding
42.42M 41.41M 40.34M 38.64M 37.81M
Weighted Average Shares Outstanding (Diluted)
42.42M 41.41M 40.34M 38.64M 37.81M
Currency in USD

Harvard Bioscience Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis